PRETAM HOLDINGS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • December 22nd, 2023 • PreTam Holdings Inc. • Concrete products, except block & brick • New York
The undersigned, PreTam Holdings Inc., a corporation incorporated under the laws of Alberta (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters”), for whom Maxim Group LLC (“Maxim”) is acting as representative (in such capacity, the “Representative”), (A) an aggregate of _______ units (the “Units”), each unit consisting of one Class A Common Share, no par value per share of the Company (“Common Stock”) and the shares of Common Stock sold as part of the Units, the “Firm Shares”) together with a warrant to purchase one share of Common Stock (the “Warrant”) at an exercise price of $_____ per share (the warrants sold as part of the Units, the “Firm Warrants”) and (B) at the election of the Representative, (i) up to an additional _________ shares of Common Stock (the “Option Shares” and together with the Firm Shares,
UNDERWRITING AGREEMENTUnderwriting Agreement • September 5th, 2023 • Edible Garden AG Inc • Agricultural production-crops • New York
MARIZYME, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 2nd, 2022 • Marizyme Inc • Pharmaceutical preparations • New York
AINOS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • August 12th, 2022 • Ainos, Inc. • Pharmaceutical preparations • New York
The undersigned, Ainos, Inc., a Texas corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”) an aggregate of 780,000 units (the “Firm Units” or “Units”) of the Company’s securities, and, at the election of the Representative, up to an additional 117,000 Option Shares (as defined herein and collectively with the shares of Common Stock underlying the Firm Units, the “Shares”), and/or up to an additional 117,000 Option Warrants (as defined herein and collectively with warrants underlying the Firm Units, the “Warrants”). Each Unit consists of one share of the Company’s common stock, par value $0.01 per share (the “Common Stock”) and one Warrant. Each Warrant entitles the holder to purchase one share of Common St
AINOS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • August 2nd, 2022 • Ainos, Inc. • Pharmaceutical preparations • New York
The undersigned, Ainos, Inc., a Texas corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”) an aggregate of [____] units (the “Firm Units” or “Units”) of the Company’s securities, and, at the election of the Representative, up to an additional [_________] Option Shares (as defined herein and collectively with the shares of Common Stock underlying the Firm Units, the “Shares”), and/or up to an additional [_____] Option Warrants (as defined herein and collectively with warrants underlying the Firm Units, the “Warrants”). Each Unit consists of one share of the Company’s common stock, par value $0.01 per share (the “Common Stock”) and one Warrant. Each Warrant entitles the holder to purchase one share of Common
EDIBLE GARDEN AG INCORPORATED UNDERWRITING AGREEMENTUnderwriting Agreement • April 6th, 2022 • Edible Garden AG Inc • Agricultural production-crops • New York
The undersigned, Edible Garden AG Incorporated, a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of [____] units (the “Firm Units” or “Units”) of the Company’s securities, and, at the election of the Representative, up to an additional [_________] Option Shares (as defined herein and collectively with the shares of Common Stock underlying the Firm Units, the “Shares”), and/or up to an additional [_____] Option Warrants (as defined herein and collectively with warrants underlying the Firm Units, the “Warrants”). Each Unit consists of one share of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) and one Warrant. Each Warrant entitles the holder to purc
IVEDA SOLUTIONS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 28th, 2022 • Iveda Solutions, Inc. • Services-prepackaged software • New York
The undersigned, Iveda Solutions, Inc., a Nevada corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of [____] shares (the “Firm Shares”) of the Company’s common stock, par value $0.00001 per share (“Common Stock”) and an aggregate of [___] warrants (the “Firm Warrants”), and, at the election of the Representative, up to an additional [_________] shares of Common Stock (the “Option Shares” and collectively with the Firm Shares, the “Shares”), and/or up to an additional [_____] warrants, (the “Option Warrants” and collectively with the Firm Warrants, the “Warrants”). Each Warrant entitles the holder to purchase one share of Common Stock (as more fully described in Section 2 hereof). The Firm
IVEDA SOLUTIONS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 15th, 2022 • Iveda Solutions, Inc. • Services-prepackaged software • New York
The undersigned, Iveda Solutions, Inc., a Nevada corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of [____] shares (the “Firm Shares”) of the Company’s common stock, par value $0.00001 per share (“Common Stock”) and an aggregate of [___] warrants (the “Firm Warrants”), and, at the election of the Representative, up to an additional [_________] shares of Common Stock (the “Option Shares” and collectively with the Firm Shares, the “Shares”), and/or up to an additional [_____] warrants, (the “Option Warrants” and collectively with the Firm Warrants, the “Warrants”). Each Warrant entitles the holder to purchase one share of Common Stock (as more fully described in Section 2 hereof). The Firm
CORPHOUSING GROUP, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • January 31st, 2022 • Corphousing Group Inc. • Real estate • New York
The undersigned, Corphousing Group, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of [____] units (the “Firm Units” or “Units”) of the Company’s securities, and, at the election of the Representative, up to an additional [_________] Option Shares (as defined herein and collectively with the shares of Common Stock underlying the Firm Units, the “Shares”), and/or up to an additional [_____] Option Warrants (as defined herein and collectively with warrants underlying the Firm Units, the “Warrants”). Each Unit consists of one share of the Company’s common stock, par value $0.00001 per share (the “Common Stock”) and one Warrant. Each Warrant entitles the holder to purchase
STAR EQUITY HOLDINGS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • January 25th, 2022 • Star Equity Holdings, Inc. • Electromedical & electrotherapeutic apparatus • New York
THIS COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Maxim Partners LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [________][181st DAY AFTER THE EFFECTIVE DATE] (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on January [ ], 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Star Equity Holdings, Inc., a Delaware corporation (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
STAR EQUITY HOLDINGS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • January 12th, 2022 • Star Equity Holdings, Inc. • Electromedical & electrotherapeutic apparatus • New York
The undersigned, Star Equity Holdings, Inc., a corporation organized under the laws of Delaware (the “Company”), hereby confirms its agreement to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), (A)(i) an aggregate of [●] shares of common stock, $0.0001 par value per share (“Common Stock”) of the Company (the “Firm Shares”), (ii) an aggregate of [●] pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of [●] shares of Common Stock, at an exercise price of $0.01 per share and (iii) an aggregate of [●] common stock purchase warrants (“Firm Purchase Warrants”) and,(B) at the election of the Representative, (i) up to an additional [●] shares of Common Stock (the “Option Shares”) and/or (ii) up to an additional [●] common stock purchase warrants (the “ Option P
SOCIETY PASS INCORPORATED UNDERWRITING AGREEMENTUnderwriting Agreement • November 12th, 2021 • Society Pass Incorporated. • Services-business services, nec • New York
BONE BIOLOGICS CORPORATION UNDERWRITING AGREEMENT 1,510,455 Units Consisting of 1,510,455 Shares of Common Stock And 1,510,455 Warrants to Purchase 1,510,455 Shares of Common StockUnderwriting Agreement • October 15th, 2021 • Bone Biologics Corp • Orthopedic, prosthetic & surgical appliances & supplies • New York
BONE BIOLOGICS CORPORATION, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as Representative (the “Representative”), an aggregate of 1,510,455 Units (the “Firm Units”), each Firm Unit consisting of one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”) and one warrant to purchase one share of Common Stock (the “Warrants” and each a “Warrant”). The 1,510,455 shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” and the Warrants referred to in this Section are hereinafter referred to as the “Firm Warrants,” and together with the Firm Units and the Firm Shares, the “Firm Securities.” The Firm Warrants shall be issued pursuant to, and shall have the rights and privileges set forth in, a warrant agent ag
BONE BIOLOGICS CORPORATION UNDERWRITING AGREEMENT [____]Units Consisting of [____]Shares of Common Stock And [____] Warrants to Purchase [ ] Shares of Common StockUnderwriting Agreement • October 6th, 2021 • Bone Biologics Corp • Orthopedic, prosthetic & surgical appliances & supplies • New York
BONE BIOLOGICS CORPORATION, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as Representative (the “Representative”), an aggregate of [____]Units (the “Firm Units”), each Firm Unit consisting of one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”) and one warrant to purchase one share of Common Stock (the “Warrants” and each a “Warrant”). The [____] shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” and the Warrants referred to in this Section are hereinafter referred to as the “Firm Warrants,” and together with the Firm Units and the Firm Shares, the “Firm Securities.” The Firm Warrants shall be issued pursuant to, and shall have the rights and privileges set forth in, a warrant agent agreement
NUTRIBAND, INC. UNDERWRITING AGREEMENT [*] Units Consisting of [*] Shares of Common Stock And [*] Warrants to Purchase [*] Shares of Common StockUnderwriting Agreement • October 1st, 2021 • NutriBand Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
NUTRIBAND, INC., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as representative (the “Representative”), an aggregate of [__] Units (the “Firm Units”), each Firm Unit consisting of one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”) and one warrant to purchase one share of Common Stock (the “Warrants” and each a “Warrant”). The [__] shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” and the Warrants referred to in this Section are hereinafter referred to as the “Firm Warrants,” and together with the Firm Units and the Firm Shares, the “Firm Securities.” The Firm Warrants shall be issued pursuant to, and shall have the rights and privileges set forth in, a warrant agent agreement, dated on or be
1,333,334 UNITS CONSISTING OF 1,333,334 SHARES OF COMMON STOCK AND 1,333,334 WARRANTS (EXERCISABLE FOR UP TO 1,333,334 SHARES) OF GAUCHO GROUP HOLDINGS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 18th, 2021 • Gaucho Group Holdings, Inc. • Land subdividers & developers (no cemeteries) • New York
The undersigned, Gaucho Group Holdings, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Gaucho Group Holdings, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Kingswood Capital Markets, division of Benchmark Investments, Inc., is acting as representative to the several Underwriters (in such capacity, the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriters) on the terms and conditions set forth herein.
DIGIRAD CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • May 29th, 2020 • Digirad Corp • Electromedical & electrotherapeutic apparatus • New York
UNDERWRITING AGREEMENT between XENETIC BIOSCIENCES, INC. and Ladenburg Thalmann & Co. Inc. XENETIC BIOSCIENCES, INC.Underwriting Agreement • October 11th, 2016 • Xenetic Biosciences, Inc. • Pharmaceutical preparations • New York
The undersigned, Xenetic Biosciences, Inc., a corporation formed under the laws of the State of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Xenetic Biosciences, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with Ladenburg Thalmann & Co. Inc. (hereinafter referred to as “you” (including its correlatives) or the “Underwriter”) as follows:
COPSYNC, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 6th, 2015 • COPsync, Inc. • Computer communications equipment • New York
The undersigned, COPsync, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of [●] Shares (“Shares”) of common stock, par value $0.0001 per share, of the Company (“Common Stock”), together with warrants to purchase an aggregate of [●] shares of Common Stock at an exercise price equal to $[●] per share (each a “Warrant” and collectively, the “Warrants”). The offering and sale of securities contemplated by this Agreement is referred to herein as the “Offering.”
COPSYNC, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 4th, 2015 • COPsync, Inc. • Computer communications equipment • New York
The undersigned, COPsync, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of [●] Shares (“Shares”) of common stock, par value $0.0001 per share, of the Company (“Common Stock”), together with Series A-1 warrants to purchase an aggregate of [●] shares of Common Stock at an exercise price equal to $[●] per share (each a “ Public Warrant” and collectively, the “ Public Warrants”) and Series A-2 warrants to purchase an aggregate of [●] shares of Common Stock at an exercise price equal to $ [●] per share (each a “ Private Warrant ” and collectively, the “ Private Warrants ”) . The offering and sale of securities contemplated by this Agreement is referred to herein as the “Offering.”
COPSYNC, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 30th, 2015 • COPsync, Inc. • Computer communications equipment • New York
The undersigned, COPsync, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of [●] Shares (“Shares”) of common stock, par value $0.0001 per share, of the Company (“Common Stock”), together with warrants to purchase an aggregate of [●] shares of Common Stock at an exercise price equal to $[●] per share (each a “Warrant” and collectively, the “Warrants”). The offering and sale of securities contemplated by this Agreement is referred to herein as the “Offering.”
COPSYNC, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 29th, 2015 • COPsync, Inc. • Computer communications equipment • New York
The undersigned, COPsync, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of [●] Shares (“Shares”) of common stock, par value $0.0001 per share, of the Company (“Common Stock”), together with warrants to purchase an aggregate of [●] shares of Common Stock at an exercise price equal to $[●] per share (each a “Warrant” and collectively, the “Warrants”). The offering and sale of securities contemplated by this Agreement is referred to herein as the “Offering.”
COPSYNC, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 8th, 2015 • COPsync, Inc. • Computer communications equipment • New York
The undersigned, COPsync, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of [●] Shares (“Shares”) of common stock, par value $0.0001 per share, of the Company (“Common Stock”), together with warrants to purchase an aggregate of [●] shares of Common Stock at an exercise price equal to $[●] per share (each a “Warrant” and collectively, the “Warrants”). The offering and sale of securities contemplated by this Agreement is referred to herein as the “Offering.”
NeuroMetrix, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • May 15th, 2015 • NeuroMetrix, Inc. • Surgical & medical instruments & apparatus • New York
The undersigned, NeuroMetrix, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of [·] units (the “Units”) of the Company’s securities. Each Unit consists of one share of the Company’s Series B convertible preferred stock, par value $0.001 per share ( “Preferred Stock”) and [·] warrants (each, a “Warrant”) with each Warrant representing the right to purchase [·] share[s] of the Company’s common stock, par value $0.0001 per share (“Common Stock”). The Preferred Stock shall have the rights, powers and preferences set forth in the certificate of designations to be dated [·], 2015 relating thereto (the “Certificate of Designations”). The shares of Common Stock issuable upon the
OPGEN, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 30th, 2015 • Opgen Inc • Services-medical laboratories • New York
The undersigned, OpGen, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of up to 3,277,500 units (“Units”) of the Company’s securities. Each Unit consists of one share of common stock, par value $0.01 per share, of the Company (“Common Stock”), and one warrant to purchase one share of Common Stock at an exercise price equal to $[·] per share (each a “Warrant” and collectively, the “Warrants”). The offering and sale of securities contemplated by this Agreement is referred to herein as the “Offering.”